$5.52 Billion is the total value of Orbimed Advisors's 127 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 29.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SVA | SINOVAC BIOTECH LTD | $340,000,000 | 0.0% | 2,718,735 | 0.0% | 6.16% | -7.7% | |
| ISRG | INTUITIVE SURGICAL INC | $212,173,770 | +33.8% | 620,500 | 0.0% | 3.84% | +23.5% | |
| Buy | ENLIVEN THERAPEUTICS INC | $183,656,079 | -6.8% | 8,998,338 | +0.0% | 3.33% | -14.0% | |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $182,818,791 | -3.6% | 3,379,900 | -10.8% | 3.31% | -11.0% |
| THESEUS PHARMACEUTICALS INC | $160,790,122 | +5.1% | 17,233,668 | 0.0% | 2.91% | -3.0% | ||
| BIIB | Buy | BIOGEN INC | $158,604,480 | +13.0% | 556,800 | +10.3% | 2.87% | +4.3% |
| HUM | HUMANA INC | $155,914,231 | -7.9% | 348,700 | 0.0% | 2.82% | -15.0% | |
| BAX | Buy | BAXTER INTL INC | $153,765,000 | +142.7% | 3,375,000 | +116.1% | 2.79% | +124.0% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $140,006,403 | -10.9% | 1,615,210 | 0.0% | 2.54% | -17.7% | |
| UNH | Sell | UNITEDHEALTH GROUP INC | $117,276,160 | -10.1% | 244,000 | -11.6% | 2.12% | -17.0% |
| EWTX | EDGEWISE THERAPEUTICS INC | $112,895,614 | +16.2% | 14,567,176 | 0.0% | 2.05% | +7.3% | |
| New | ACELYRIN INC | $111,319,712 | – | 5,326,302 | +100.0% | 2.02% | – | |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $109,562,577 | -5.4% | 4,178,588 | -7.1% | 1.98% | -12.7% |
| DISC MEDICINE INC | $100,771,883 | +109.5% | 2,269,637 | 0.0% | 1.83% | +93.4% | ||
| BMY | Sell | BRISTOL-MYERS SQUIBB CO | $95,157,600 | -41.3% | 1,488,000 | -36.4% | 1.72% | -45.9% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $89,014,585 | +17.2% | 2,169,500 | +2.1% | 1.61% | +8.2% |
| UTHR | New | UNITED THERAPEUTICS CORP DEL | $88,719,425 | – | 401,900 | +100.0% | 1.61% | – |
| EVH | EVOLENT HEALTH INCcl a | $87,737,650 | -6.6% | 2,895,632 | 0.0% | 1.59% | -13.8% | |
| VECT | VECTIVBIO HLDG AG | $87,661,537 | +99.8% | 5,156,561 | 0.0% | 1.59% | +84.4% | |
| LLY | LILLY ELI & CO | $87,230,280 | +36.6% | 186,000 | 0.0% | 1.58% | +26.1% | |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $84,940,900 | -0.3% | 162,800 | +10.1% | 1.54% | -8.0% |
| APLS | APELLIS PHARMACEUTICALS INC | $82,919,220 | +38.1% | 910,200 | 0.0% | 1.50% | +27.4% | |
| SYK | Sell | STRYKER CORPORATION | $82,801,426 | -21.1% | 271,400 | -26.2% | 1.50% | -27.2% |
| VRNA | Sell | VERONA PHARMA PLCsponsored ads | $79,862,227 | -6.7% | 3,777,778 | -11.3% | 1.45% | -13.9% |
| THC | Sell | TENET HEALTHCARE CORP | $78,165,490 | +7.8% | 960,500 | -21.3% | 1.42% | -0.5% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $74,896,080 | -37.2% | 654,000 | -24.4% | 1.36% | -42.0% |
| MDGL | New | MADRIGAL PHARMACEUTICALS INC | $74,282,439 | – | 321,569 | +100.0% | 1.35% | – |
| CRNX | CRINETICS PHARMACEUTICALS IN | $71,193,344 | +12.2% | 3,950,796 | 0.0% | 1.29% | +3.5% | |
| CMPX | COMPASS THERAPEUTICS INC | $71,113,863 | -2.8% | 22,362,850 | 0.0% | 1.29% | -10.2% | |
| XTNT | XTANT MED HLDGS INC | $67,989,259 | +45.9% | 73,114,592 | 0.0% | 1.23% | +34.6% | |
| TERN | TERNS PHARMACEUTICALS INC | $66,667,431 | -26.1% | 7,619,135 | 0.0% | 1.21% | -31.8% | |
| PRELUDE THERAPEUTICS INCnonvoting | $66,334,294 | +23.3% | 11,895,652 | 0.0% | 1.20% | +13.7% | ||
| Buy | R1 RCM INC | $63,486,450 | +141.9% | 3,441,000 | +96.6% | 1.15% | +123.3% | |
| SIBN | Sell | SI-BONE INC | $61,852,486 | +7.7% | 2,292,531 | -21.5% | 1.12% | -0.5% |
| KROS | Sell | KEROS THERAPEUTICS INC | $60,862,012 | -15.1% | 1,514,734 | -9.8% | 1.10% | -21.7% |
| SBTX | ARS PHARMACEUTICALS INC | $58,563,943 | +2.9% | 8,740,887 | 0.0% | 1.06% | -5.0% | |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $58,205,914 | +4.0% | 165,400 | -6.9% | 1.06% | -3.9% |
| SCPH | SCPHARMACEUTICALS INC | $56,651,590 | +12.3% | 5,559,528 | 0.0% | 1.03% | +3.6% | |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $52,957,923 | +46.5% | 2,530,240 | +47.8% | 0.96% | +35.2% |
| PCVX | Buy | VAXCYTE INC | $50,296,971 | +84.0% | 1,007,148 | +38.1% | 0.91% | +69.6% |
| PRLD | Buy | PRELUDE THERAPEUTICS INC | $49,091,652 | -14.2% | 10,909,256 | +8.7% | 0.89% | -20.7% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $48,579,950 | -6.8% | 515,000 | -18.3% | 0.88% | -14.0% |
| NTRA | NATERA INC | $47,374,451 | -12.4% | 973,581 | 0.0% | 0.86% | -19.1% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $46,112,700 | -6.8% | 489,000 | 0.0% | 0.84% | -14.0% | |
| CI | New | THE CIGNA GROUP | $45,176,600 | – | 161,000 | +100.0% | 0.82% | – |
| XENE | Sell | XENON PHARMACEUTICALS INC | $42,196,000 | +2.6% | 1,096,000 | -4.6% | 0.76% | -5.2% |
| ALPN | ALPINE IMMUNE SCIENCES INC | $41,958,766 | +33.2% | 4,081,592 | 0.0% | 0.76% | +22.8% | |
| PMVP | PMV PHARMACEUTICALS INC | $41,084,862 | +31.2% | 6,563,077 | 0.0% | 0.74% | +21.0% | |
| ZBH | New | ZIMMER BIOMET HOLDINGS INC | $35,672,000 | – | 245,000 | +100.0% | 0.65% | – |
| RPTX | REPARE THERAPEUTICS INC | $35,151,923 | +7.5% | 3,322,488 | 0.0% | 0.64% | -0.8% | |
| GRCL | Sell | GRACELL BIOTECHNOLOGIES INCsponsored ads | $34,418,496 | +94.8% | 9,033,726 | -4.9% | 0.62% | +79.8% |
| JANX | JANUX THERAPEUTICS INC | $33,667,902 | -1.9% | 2,836,386 | 0.0% | 0.61% | -9.5% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $33,140,504 | +15.2% | 4,707,458 | 0.0% | 0.60% | +6.2% | |
| MRTX | MIRATI THERAPEUTICS INC | $33,010,175 | -2.8% | 913,650 | 0.0% | 0.60% | -10.3% | |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $32,541,740 | +49.1% | 316,400 | +58.2% | 0.59% | +37.5% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $32,534,016 | -17.1% | 2,118,100 | +21.4% | 0.59% | -23.4% |
| TELA | Sell | TELA BIO INC | $28,724,040 | -10.8% | 2,835,542 | -6.3% | 0.52% | -17.7% |
| AMGN | Buy | AMGEN INC | $28,263,146 | +52.4% | 127,300 | +66.0% | 0.51% | +40.7% |
| VERA | Buy | VERA THERAPEUTICS INCcl a | $28,196,640 | +166.7% | 1,756,800 | +28.9% | 0.51% | +145.7% |
| THIRD HARMONIC BIO INC | $27,797,332 | +16.7% | 5,779,071 | 0.0% | 0.50% | +7.9% | ||
| ABCL | ABCELLERA BIOLOGICS INC | $27,007,761 | -14.3% | 4,180,768 | 0.0% | 0.49% | -21.0% | |
| KNTE | Buy | KINNATE BIOPHARMA INC | $24,269,479 | -24.5% | 8,009,729 | +55.7% | 0.44% | -30.3% |
| 2SEVENTY BIO INC | $24,203,275 | -0.8% | 2,391,628 | 0.0% | 0.44% | -8.4% | ||
| MRSN | Sell | MERSANA THERAPEUTICS INC | $23,737,143 | -35.9% | 7,214,937 | -19.9% | 0.43% | -40.9% |
| QURE | UNIQURE NV | $23,658,654 | -43.1% | 2,064,455 | 0.0% | 0.43% | -47.4% | |
| RAPT | RAPT THERAPEUTICS INC | $23,395,009 | +1.9% | 1,251,070 | 0.0% | 0.42% | -6.0% | |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $23,316,384 | +79.5% | 1,856,400 | +58.5% | 0.42% | +65.5% |
| ALXO | ALX ONCOLOGY HLDGS INC | $21,561,210 | +66.2% | 2,871,000 | 0.0% | 0.39% | +53.3% | |
| IKNA | IKENA ONCOLOGY INC | $20,901,249 | +90.1% | 3,186,166 | 0.0% | 0.38% | +75.5% | |
| ACET | Buy | ADICET BIO INC | $20,222,800 | -52.9% | 8,322,140 | +11.7% | 0.37% | -56.5% |
| DBTX | DECIBEL THERAPEUTICS INC | $19,038,989 | +27.5% | 4,945,192 | 0.0% | 0.34% | +17.7% | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $18,244,985 | -13.4% | 1,914,479 | 0.0% | 0.33% | -19.9% | |
| NPCE | NEUROPACE INC | $18,015,142 | -3.2% | 4,012,281 | 0.0% | 0.33% | -10.7% | |
| Sell | VENTYX BIOSCIENCES INC | $17,744,275 | -9.5% | 540,984 | -7.5% | 0.32% | -16.4% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $15,900,968 | +151.6% | 6,943,654 | 0.0% | 0.29% | +132.3% | |
| FUSN | FUSION PHARMACEUTICALS INC | $14,583,336 | +23.9% | 3,122,770 | 0.0% | 0.26% | +14.3% | |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $13,839,019 | +173.4% | 7,133,515 | +22.6% | 0.25% | +153.5% |
| BAX | Sell | BAXTER INTL INCcall | $13,668,000 | -3.7% | 300,000 | -14.3% | 0.25% | -11.1% |
| KZR | KEZAR LIFE SCIENCES INC | $13,384,350 | -21.7% | 5,463,000 | 0.0% | 0.24% | -27.7% | |
| AVTE | AEROVATE THERAPEUTICS INC | $12,981,350 | -15.0% | 756,930 | 0.0% | 0.24% | -21.7% | |
| ARGX | Sell | ARGENX SEsponsored adr | $12,705,198 | -23.4% | 32,600 | -26.7% | 0.23% | -29.2% |
| MORF | New | MORPHIC HLDG INC | $11,953,305 | – | 208,500 | +100.0% | 0.22% | – |
| New | VERASTEM INC | $11,376,616 | – | 1,529,115 | +100.0% | 0.21% | – | |
| HUM | New | HUMANA INCcall | $11,178,250 | – | 25,000 | +100.0% | 0.20% | – |
| IMTX | Buy | IMMATICS N.V | $11,157,207 | +70.7% | 966,829 | +2.1% | 0.20% | +57.8% |
| GDRX | Buy | GOODRX HLDGS INC | $9,873,072 | -7.1% | 1,788,600 | +5.2% | 0.18% | -14.4% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $9,700,290 | -50.8% | 13,500 | -43.8% | 0.18% | -54.5% |
| GLTO | Sell | GALECTO INC | $9,662,277 | +18.7% | 3,834,237 | -6.3% | 0.18% | +9.4% |
| PASG | Buy | PASSAGE BIO INC | $9,530,263 | +11.4% | 10,124,576 | +13.4% | 0.17% | +3.0% |
| AKRO | New | AKERO THERAPEUTICS INC | $9,314,655 | – | 199,500 | +100.0% | 0.17% | – |
| Sell | BRIDGEBIO PHARMA INCnote 2.250% 2/0 | $9,265,350 | -27.9% | 15,000,000 | -25.0% | 0.17% | -33.3% | |
| ORIC | Sell | ORIC PHARMACEUTICALS INC | $9,067,312 | +15.7% | 1,168,468 | -15.0% | 0.16% | +6.5% |
| GHRS | Sell | GH RESEARCH PLCordinary shares | $8,736,377 | -34.1% | 736,315 | -55.6% | 0.16% | -39.2% |
| THC | New | TENET HEALTHCARE CORPcall | $8,138,000 | – | 100,000 | +100.0% | 0.15% | – |
| GILD | New | GILEAD SCIENCES INC | $7,707,000 | – | 100,000 | +100.0% | 0.14% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $5,967,000 | – | 117,000 | +100.0% | 0.11% | – | |
| Buy | YS BIOPHARMA CO LTDordinary shares | $5,931,882 | -13.7% | 4,298,465 | +0.0% | 0.11% | -20.7% | |
| CUTR | New | CUTERA INC | $5,856,823 | – | 387,100 | +100.0% | 0.11% | – |
| CGEM | Sell | CULLINAN ONCOLOGY INC | $5,862,564 | -5.3% | 544,848 | -10.0% | 0.11% | -13.1% |
| SRRK | Buy | SCHOLAR ROCK HLDG CORP | $5,546,763 | +34.6% | 735,645 | +42.8% | 0.10% | +24.7% |
| INVIVYD INC | $5,533,920 | -12.5% | 5,270,400 | 0.0% | 0.10% | -19.4% | ||
| HZNP | HORIZON THERAPEUTICS PUB Lput | $5,142,500 | -5.8% | 50,000 | 0.0% | 0.09% | -13.1% | |
| NXTC | NEXTCURE INC | $4,879,823 | +21.6% | 2,711,013 | 0.0% | 0.09% | +11.4% | |
| ALKS | New | ALKERMES PLC | $4,738,820 | – | 151,400 | +100.0% | 0.09% | – |
| NSPR | New | INSPIREMD INC | $4,669,617 | – | 1,860,405 | +100.0% | 0.08% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $4,172,220 | – | 117,000 | +100.0% | 0.08% | – |
| VIGIL NEUROSCIENCE INC | $4,219,575 | -4.0% | 448,891 | 0.0% | 0.08% | -11.6% | ||
| APOLLOMICS INC | $3,796,475 | -76.3% | 662,561 | 0.0% | 0.07% | -78.1% | ||
| BCAB | Sell | BIOATLA INC | $3,468,525 | -66.5% | 1,156,175 | -70.1% | 0.06% | -69.0% |
| CMMB | CHEMOMAB THERAPEUTICS LTDsponsored ads | $2,947,275 | -17.3% | 2,241,274 | 0.0% | 0.05% | -24.3% | |
| SYBX | SYNLOGIC INC | $2,592,898 | -32.0% | 6,029,995 | 0.0% | 0.05% | -37.3% | |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $2,531,000 | +57.2% | 100,000 | +100.0% | 0.05% | +43.8% |
| EPIX | Sell | ESSA PHARMA INC | $2,489,238 | -30.1% | 921,940 | -23.1% | 0.04% | -35.7% |
| AFIB | ACUTUS MED INC | $2,351,767 | +17.8% | 2,648,386 | 0.0% | 0.04% | +10.3% | |
| ELEV | New | ELEVATION ONCOLOGY INC | $2,280,000 | – | 1,500,000 | +100.0% | 0.04% | – |
| BOLT | BOLT BIOTHERAPEUTICS INC | $1,972,480 | -7.9% | 1,541,000 | 0.0% | 0.04% | -14.3% | |
| TARA | Sell | PROTARA THERAPEUTICS INC | $1,846,476 | -25.7% | 772,584 | -2.6% | 0.03% | -32.7% |
| PHGE | Buy | BIOMX INC | $1,639,256 | +70.0% | 4,553,489 | +44.0% | 0.03% | +57.9% |
| New | CALCIMEDICA INC | $1,192,494 | – | 297,380 | +100.0% | 0.02% | – | |
| TGTX | New | TG THERAPEUTICS INCcall | $1,137,672 | – | 45,800 | +100.0% | 0.02% | – |
| HRTX | HERON THERAPEUTICS INC | $931,132 | -23.2% | 802,700 | 0.0% | 0.02% | -29.2% | |
| MRSN | Buy | MERSANA THERAPEUTICS INCcall | $822,500 | -5.0% | 250,000 | +18.7% | 0.02% | -11.8% |
| HARP | HARPOON THERAPEUTICS INC | $441,065 | -4.6% | 621,218 | 0.0% | 0.01% | -11.1% | |
| OMIC | SINGULAR GENOMICS SYSTEMS IN | $448,779 | -31.4% | 540,697 | 0.0% | 0.01% | -38.5% | |
| ALT | Buy | ALTIMMUNE INC | $353,000 | +65.3% | 100,000 | +97.6% | 0.01% | +50.0% |
| NKTR | Sell | NEKTAR THERAPEUTICScall | $296,228 | -22.7% | 515,000 | -5.5% | 0.01% | -37.5% |
| ALT | Exit | ALTIMMUNE INCcall | $0 | – | -100,000 | -100.0% | -0.01% | – |
| AGLE | Exit | AEGLEA BIOTHERAPEUTICS INC | $0 | – | -1,797,221 | -100.0% | -0.01% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -1,034,059 | -100.0% | -0.01% | – |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCspon ads | $0 | – | -7,747,891 | -100.0% | -0.11% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INCcall | $0 | – | -150,000 | -100.0% | -0.11% | – |
| NTLA | Exit | INTELLIA THERAPEUTICS INC | $0 | – | -164,627 | -100.0% | -0.12% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -16,503,237 | -100.0% | -0.14% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -301,000 | -100.0% | -0.14% | – |
| XBI | Exit | SPDR SER TRcall | $0 | – | -100,000 | -100.0% | -0.15% | – |
| Exit | BRIDGEBIO PHARMA INCnote 2.500% 3/1 | $0 | – | -12,500,000 | -100.0% | -0.19% | – | |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -75,000 | -100.0% | -0.20% | – |
| Exit | RXSIGHT INC | $0 | – | -1,202,833 | -100.0% | -0.39% | – | |
| XBI | Exit | SPDR SER TRs&p biotech | $0 | – | -274,000 | -100.0% | -0.41% | – |
| Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -813,500 | -100.0% | -0.47% | – | |
| PGNY | Exit | PROGYNY INC | $0 | – | -1,037,912 | -100.0% | -0.65% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -5,108,900 | -100.0% | -0.72% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -2,029,300 | -100.0% | -0.92% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 41 | Q2 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 41 | Q2 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 41 | Q2 2023 | 3.2% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| NEUROCRINE BIOSCIENCES INC | 40 | Q2 2023 | 2.7% |
| SINOVAC BIOTECH LTD | 40 | Q2 2023 | 6.7% |
| BOSTON SCIENTIFIC CORP | 39 | Q2 2023 | 5.6% |
| AMGEN INC | 39 | Q2 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 39 | Q2 2023 | 3.8% |
| GILEAD SCIENCES INC | 38 | Q2 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adicet Bio, Inc. | June 29, 2023 | 6,647,598 | 15.5% |
| Passage BIO, Inc. | June 29, 2023 | 8,034,000 | 14.7% |
| Disc Medicine, Inc. | June 21, 2023 | 2,269,637 | 10.2% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| SpringWorks Therapeutics, Inc. | May 17, 2023 | 4,178,588 | 6.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
| Kinnate Biopharma Inc. | May 08, 2023 | 7,559,729 | 16.2% |
| TELA Bio, Inc. | April 21, 2023 | 2,866,267 | 11.9% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4/A | 2023-09-21 |
| SC 13D/A | 2023-09-21 |
| SC 13D/A | 2023-09-18 |
| 4 | 2023-09-14 |
| SC 13D/A | 2023-09-14 |
| SC 13D/A | 2023-09-05 |
| 4 | 2023-08-31 |
| 144 | 2023-08-30 |
| 144 | 2023-08-30 |
| SC 13D/A | 2023-08-23 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.